Labshake search
Citations for R&D Systems :
1 - 50 of 372 citations for 7 Methoxyquinoline 3 carboxamide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2022Quote: ... 0.03 to 3 μg/well of the soluble mouse or human HA-tagged recombinant fibulin 7 (R&D Systems) in 2% dry milk/TBS and 2 mM CaCl2 were added to the wells and incubated for 3 hours ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Molecular Biology 2022Quote: ... dTAG-7 (R&D Systems), at the final concentration of 500 nM ...
-
bioRxiv - Neuroscience 2020Quote: Caspase 3/7 activity was measured using a chromogenic DEVD cleavage assay according to manufacturer’s instructions (R&D Systems, Minneapolis, MN, #K106-100).
-
bioRxiv - Immunology 2020Quote: ... ELISA for IL-7 was performed using Mouse IL-7 Quantikine ELISA Kit M700 (R&D Systems) according to manufacturer’s instructions.
-
bioRxiv - Bioengineering 2023Quote: ... IL-7 (5ng/ml; R&D Systems) and IL-15 (5ng/ml ...
-
bioRxiv - Cell Biology 2020Quote: ... 10 ng/ml IL-7 (R&D Systems), 3 units/ml EPO for the second week and 10 ng/ml IL-7 and 3 units/ml EPO only for the third week ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-7 (R&D Systems), 5 ng/ml IL-15 (R&D Systems) ...
-
bioRxiv - Bioengineering 2022Quote: ... 120 IU/mL IL-7 (R&D systems), and 20 IU/mL IL-15 (R&D systems) ...
-
bioRxiv - Cancer Biology 2022Quote: ... A Galectin-7 ELISA kit (R&D Systems) was used to measure its concentration in the plasma of patients.
-
bioRxiv - Immunology 2022Quote: ... IL-7 (R&D Systems, 207-IL-025) was supplemented to the media on Days 9 ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Molecular Biology 2022Quote: ... treated (‘+’) or not (‘-’) with dTAG-7 (R&D Systems) at the final concentration of 500 nM ...
-
bioRxiv - Molecular Biology 2022Quote: ... treated or not with dTAG-7 (R&D Systems) at the final concentration of 500 nM ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.02µg/mL IL-7(R&D Systems, 207-IL), 0.01µg/mL IL-3 (R&D Systems ...
-
bioRxiv - Systems Biology 2021Quote: ... and mice fibroblast growth factor 7 (R&D system), 30μg/mL bovine pituitary extract (Gibco) ...
-
bioRxiv - Immunology 2020Quote: ... 5ng/mL each of IL-7 (R&D Systems) and IL-15 (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... or IL-7 (20 ng/mL; R&D Systems). After 24 hr (day 1) ...
-
bioRxiv - Immunology 2023Quote: ... with 7 µg IL-15Rα-Fc (R&D Systems) and incubating for 20-30 min at 37°C prior to injection ...
-
bioRxiv - Immunology 2021Quote: ... magnetically isolated T cells were resuspended in the complete medium and were seeded in a 10-cm petri dish or T-75 flask at 1–2×106 cells/cm2 and cultured in the presence of 20 ng/mL recombinant mouse interleukin-7 (rmIL-7; 402-ML-020/CF, R&D Systems, Minneapolis, MN) for 24 hr at 37°C in a humidified 5% CO2 atmosphere.
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Immunology 2021Quote: ... 20ng/ml mouse IL-7 (R&D System 407-ML) and 20ng/ml mouse IL-15 (R&D System 447-ML) ...
-
bioRxiv - Immunology 2023Quote: ... IL-7 (10 ng/ml; R&D Systems, 207-IL), and TNFα (4.9 ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Neuroscience 2022Quote: ... sonic hedgehog C25II (days 2-7, 100ng/mL, R&D Systems). After day 13 of differentiation ...
-
bioRxiv - Immunology 2020Quote: ... IL-7 and stem cell factor (all from R&D systems) in α-MEM (Gibco ...
-
bioRxiv - Immunology 2022Quote: ... and IL-7 (50 ng/ml, R&D systems, #407-ML). After 2 to 4 weeks ...
-
bioRxiv - Biochemistry 2023Quote: ... His10-FLAG-BRD4 (0.2 μL, 7 μM, R&D Systems, SP600100), ubiquitin (10 μL ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3) were purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Cell Biology 2023Quote: ... 2ng/mL rhIL-7 and 0.4ng/mL rhIL-15 (R&D Systems). T cells were transduced 24 hours post-activation with lentivirus encoding an anti-EGFR CAR with 41bb/CD3ζ ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Molecular Biology 2020Quote: Randomly selected sections coming from ovarian tissue of least 3 different individuals were used for immunohistochemistry for Anti-active Caspase-3 (AC-3, 1:1000, AF-835, R&D Systems), γH2AX (1:250 IHC-00059 ...
-
bioRxiv - Cell Biology 2023Quote: ... mouse Integrin alpha 7 Alexa Fluor 750-conjugated Antibody (FAB3518S, R&D Systems), APC anti-mouse CD45 Antibody (103111 ...
-
bioRxiv - Bioengineering 2023Quote: ... induction of intermediate mesoderm began using 7 µM CHIR99021 (R&D Systems, 4423), a Wnt agonist ...
-
bioRxiv - Bioengineering 2022Quote: ... α3 (MAB1345; R&D systems), β4 (NBP1-43369) ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 5 ng mL-1 of IL-7 and IL-15 (R&D Systems). Regulatory T cells were activated at 1 x 106 cells mL-1 for 2 days in complete XVivo15 supplemented with magnetic Treg Xpander CTS Dynabeads (ThermoFisher ...
-
bioRxiv - Developmental Biology 2022Quote: ... Mesoderm lineage explants were generated using recombinant BMP4/7 heterodimer protein (R&D Systems) at a final concentration of 20g/mL in 1xMMR supplemented with 0.1% BSA ...
-
bioRxiv - Immunology 2019Quote: ... 5 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems).
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Immunology 2023Quote: ... in media containing 10 ng/ml IL-7 (BT-007-010; R&D Systems) at 37°C in 5% CO2 and after 3.5 days ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems). After 14 days ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Cell Biology 2020Quote: ... SCs were sorted based on positive alpha 7-integrin (1:100, R&D Systems FAB3518P) and absence of Sca1 (1:1000 ...
-
bioRxiv - Cell Biology 2023Quote: ... positive selection marker: Mouse anti-integrin alpha 7 Alexa fluor 647 (FAB3518R, R&D Systems). Cells were rinsed ...
-
bioRxiv - Neuroscience 2023Quote: HiPSCs-derived microglia at day 7 of differentiation were stimulated with IFNγ (R&D Systems) 100 ng/ml for 72 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... and differentiating spermatogonia marker c-KIT (day 7; 0.6 µg/ml, R&D Systems AF2944) overnight at 4 °C ...
-
bioRxiv - Pathology 2020Quote: ... goat polyclonal anti YM1/Chitinase-3 like 3 (R&D systems, Cat. No. AF2446, 1:400 dilution). Antigen retrieval of HIER2 (EDTA ...